Welcome to our exciting symposium on precision cancer medicine!
The symposium is a joint effort of the Finnish Cancer Institute and iCAN, the Finnish R&D Flagship for digital precision cancer medicine. We offer 300 participants the possibility to join this multidisciplinary event combining clinical and experimental research on site.
List of confirmed speakers and tentative titles can be found on our website
Registration including abstract submission will open in late April.
Please spread the message to your colleagues!
On behalf of the organizing committee:
Johanna Arola, chair
Tomi Mäkelä, vice chair